Search Results - "Tré-Hardy, Marie"

PubPharm (32)

1

An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens

in: Journal of clinical medicine | Vol. 9, No. 11 (2020)

by Gillot, C. | Douxfils, J. | Cadrobbi, J. | +8

2

Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods : Experiences of a general hospital

in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | Vol. 129 (2020), p. 104472

by Blairon, L. | Wilmet, A. | Beukinga, I. | +1

CommentOn: Front Med (Lausanne). 2020 May 08;7:225. - PMID 32574326

3

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies

in: Clinical biochemistry | (25.08.2020)

by Mairesse, A. | Favresse, J. | Eucher, C. | +7

4

The role of serology for COVID-19 control : Population, kinetics and test performance do matter

in: The Journal of infection | Vol. 81, No. 2 (2020), p. e91-e92

by Tré-Hardy, M. | Blairon, L. | Wilmet, A. | +4

5

Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies

in: Clinical chemistry | Vol. 66, No. 8 (2020), p. 1104-1106

by Favresse, J. | Eucher, C. | Elsen, M. | +3

6

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

in: The Journal of infection | (31.07.2020)

by Blairon, L. | Mokrane, S. | Wilmet, A. | +4

7

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

in: Clinical chemistry and laboratory medicine | Vol. 58, No. 8 (2020), p. 1357-1364

by Tré-Hardy, M. | Wilmet, A. | Beukinga, I. | +3

8

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies

in: Journal of medical virology | (15.07.2020)

by Tré-Hardy, M. | Wilmet, A. | Beukinga, I. | +4

9

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

enthalten in: BMC public health | 2019

by Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

10

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population : the experience of Belgium

in: BMC public health | Vol. 19, No. 1 (2019), p. 597

by Lernout, T. | Kabamba-Mukadi, B. | Saegeman, V. | +6

1
2
3
4
Next »
[4]